Methods and systems for the inhibition of vascular hyperplasia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6503243
SERIAL NO

09653033

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Post-interventional neointimal hyperplasia in arteries is treated by the application of ultrasonic energy. Usually, an intravascular catheter having an interface surface is positioned at a target site in the artery which has previously been treated. The interface surface is vibrationally excited to apply energy to the arterial wall in a manner which inhibits smooth muscle cell proliferation in the neointimal layer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMASONICS INC1024 MORSE AVENUE SUNNYVALE CA 94089

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brisken, Axel F Fremont, CA 98 14605

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation